Journal ArticleOPEN ACCESS

Anti–PD-1–Related Pneumonitis during Cancer Immunotherapy

  • Nishino M
  • Sholl L
  • Hatabu H
  • et al.
New England Journal of Medicine (2015) 373(3) 288-290
DOI: 10.1056/nejmc1505197
348Citations
Citations of this article
178Readers
Mendeley users who have this article in their library.

Abstract

Among three patients with melanoma receiving anti–PD-1 antibodies, the use of checkpoint blockers led to the development of serious autoimmune pneumonitis, a potentially lethal complication.

Cite

CITATION STYLE

APA

Nishino, M., Sholl, L. M., Hatabu, H., Ramaiya, N. H., & Hodi, F. S. (2015). Anti–PD-1–Related Pneumonitis during Cancer Immunotherapy. New England Journal of Medicine, 373(3), 288–290. https://doi.org/10.1056/nejmc1505197

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free